The store will not work correctly when cookies are disabled.
Erythribyssin O
ID: ALA1096406
PubChem CID: 46861837
Max Phase: Preclinical
Molecular Formula: C21H18O5
Molecular Weight: 350.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: Erythribyssin O | Erythribyssin O|CHEMBL1096406|BDBM50317435
Canonical SMILES: CC(C)=CCc1c(O)ccc2c3c(oc12)-c1cc(C=O)c(O)cc1OC3
Standard InChI: InChI=1S/C21H18O5/c1-11(2)3-4-14-17(23)6-5-13-16-10-25-19-8-18(24)12(9-22)7-15(19)21(16)26-20(13)14/h3,5-9,23-24H,4,10H2,1-2H3
Standard InChI Key: AGFXXWXSPAYWMF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
13.9128 -1.4762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9117 -2.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6251 -2.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6233 -1.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3372 -1.4726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3361 -2.3041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7739 -1.4747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0539 -1.0556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7727 -2.3061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0507 -2.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2187 -3.5312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3870 -2.8657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0443 -3.6197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5255 -4.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3495 -4.2104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6899 -3.4519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2066 -2.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1997 -1.0647 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7699 -4.9185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1107 -5.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2873 -4.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8729 -5.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0495 -5.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2818 -6.4259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1983 -2.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1976 -3.5364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
12 13 2 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 2 0
5 8 1 0
15 16 1 0
6 10 1 0
16 17 2 0
17 12 1 0
9 7 1 0
1 18 1 0
7 8 1 0
15 19 1 0
9 10 2 0
14 20 1 0
5 4 2 0
20 21 1 0
4 1 1 0
21 22 2 0
5 6 1 0
22 23 1 0
10 11 1 0
22 24 1 0
11 13 1 0
2 25 1 0
9 12 1 0
25 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.37 | Molecular Weight (Monoisotopic): 350.1154 | AlogP: 4.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.90 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.61 | CX Basic pKa: ┄ | CX LogP: 4.78 | CX LogD: 4.55 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.53 | Np Likeness Score: 1.87 |
References
1. Nguyen PH, Nguyen TN, Kang KW, Ndinteh DT, Mbafor JT, Kim YR, Oh WK.. (2010) Prenylated pterocarpans as bacterial neuraminidase inhibitors., 18 (9): [PMID:20363636] [10.1016/j.bmc.2010.03.005] |